This is a success message.
This is an error message.
This is also an error message.
Company news

z-Movi featured in Science

Our latest product, the z-Movi®;, has been featured in the latest issue of the journal Science!

The z-Movi uses acoustic force manipulation to query the interaction strengths of cells with their cognate binding partners. It is based on a lab-on-a-chip assay that allows the assessment of thousands of cell-cell and cell-ligand interactions in parallel. The technology provides an accurate, label-free method to sort cells based on their avidity to specific targets, such as (tumor) cells, proteins, peptides and viruses.

Interested in using the z-Movi; for your own experiments? Feel free to contact us for a demo or a quote.

Latest news & press

Keep up with everything we’re doing

View all
Amgen-LUMICKS collaborative research will be presented at PEGS Europ
Amgen-LUMICKS collaborative research will be presented at PEGS Europ
Company news
November 12, 2026
01-01-20

This is some text inside of a div block.
Congratulations to Dr. Samuel Katz, Recipient of the LUMICKS Cell Avidity Travel Award
Congratulations to Dr. Samuel Katz, Recipient of the LUMICKS Cell Avidity Travel Award
Company news
October 13, 2026
01-01-20

This is some text inside of a div block.
LUMICKS is collaborating with Amgen to measure Cell Avidity to better understand T-cell engagers
LUMICKS is collaborating with Amgen to measure Cell Avidity to better understand T-cell engagers
Company news
September 30, 2026
01-01-20

This is some text inside of a div block.
LUMICKS Receives Innovation Champion Award at TechEU Equity Summit 2026
LUMICKS Receives Innovation Champion Award at TechEU Equity Summit 2026
Company news
September 25, 2026
01-01-20

This is some text inside of a div block.